Geschäft

November 2019, Global & German Médicaments Contre La Dysfonction Érectile Markt von Trends, Bedrohungen, Aktien und Chancen und Wachstumsprognose bis 2026

Report Scope:

Market Segment by Manufacturers, this report covers
  Eli Lilly
  Metuchen Pharma
  BaiYunShan General Factory
  Pfizer
  Dong-A ST
  Bayer
  CSBIO.
  Teva Pharma
  S.K. Chemicals
  Seoul Pharma

Market Segment by Regions, regional analysis covers
  North America (United States, Canada and Mexico)
  Europe (Germany, France, UK, Russia and Italy)
  Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  South America (Brazil, Argentina, Colombia etc.)
  Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  Sildenafil
  Tadalafil
  Others

In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Market Segment by Applications, can be divided into
  Hospital Pharmacies
  Private Clinics
  Retail Pharmacies
  E-Commerce (B2B)
  E-Commerce (B2C)

In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

Related Articles

Close